Thomas Zindrick
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Thomas D.
Zindrick is Chairman, President & Chief Executive Officer at Genelux Corp.
since 2023 and Executive Vice Chairman at Aeromics, Inc. since 2018.
Former roles include Director at DNX Biopharmaceuticals, Inc. from 2014 to 2020, Director at Amitech Therapeutic Solutions, Inc. from 2014 to 2021, Attorney at The Dow Chemical Co., and Vice President & Associate General Counsel at Amgen, Inc. from 2008 to 2009.
Education includes undergraduate studies at North Central College and graduate studies at the University of Illinois College of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENELUX CORP. 1,19 % | 11/05/2026 | 532.051 ( 1,19 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENELUX CORPORATION | Director Ejecutivo | 28/05/2014 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Director/Miembro de la Junta | 16/08/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Amitech Therapeutic Solutions, Inc | Director Ejecutivo | 01/02/2021 |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic proteins for the treatment of patients with life-long diseases | Director/Miembro de la Junta | 01/03/2020 |
| AMGEN INC. | Oficial de Cumplimiento | 01/01/2008 |
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Health Technology |
North Central College
North Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois College of Law
University of Illinois College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic proteins for the treatment of patients with life-long diseases | Commercial Services |
Amitech Therapeutic Solutions, Inc |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.